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Human neural progenitor cells (hNPCs) have previously been generated from limited numbers of human induced pluripotent
stem cell (hiPSC) clones. Here, 21 hiPSC clones derived from human dermal fibroblasts, cord blood cells, and peripheral blood
mononuclear cells were differentiated using two neural induction methods, an embryoid body (EB) formation-based method and
an EB formation method using dual SMAD inhibitors (dSMADi). Our results showed that expandable hNPCs could be generated
from hiPSC clones with diverse somatic tissue origins. The established hNPCs exhibited a mid/hindbrain-type neural identity and
uniform expression of neural progenitor genes.
1. Introduction
Human neural progenitor cells (hNPCs), which are present
in fetal and adult neural tissues, have the potential to be ther-
apeutically beneficial in the treatment of neuronal diseases
such as spinal cord injury or stroke; however, it is technically
difficult to obtain hNPCs from human neural tissues. The
development of human embryonic stem cells (hESCs) [1] and
human induced pluripotent stem cells (hiPSCs) [2, 3] has
greatly improved the prospects of regenerative medicine. We
are now able to obtain unlimited hiPSCs from every somatic
tissue source [4]. However, hiPSC clones exhibit variable
differentiation propensities [5], similar to hESCs [6].
Many protocols have been reported for the neural induc-
tion of hESCs/hiPSCs. Transplantable neural precursors were
first derived from hESCs, which were subjected to sponta-
neous embryoid body (EB) formation, followed by neural
rosette selection [7]. EB-mediated neural rosette formation
is used not only for establishing rosette-stage neural stem
cells (R-NSCs) from hESCs [8], but also for generating long-
term self-renewing neuroepithelial-like stem (lt-NES) cells
from hESCs/hiPSCs [9, 10]. However, the neural induction
efficiency of these methods depends on the innate differen-
tiation propensity of the hESC/hiPSC clones [11]. Using a
strategy based on the neural default model, inhibitors of the
bone morphogenic protein (BMP) signaling pathway, such
as Noggin or the small molecule Dorsomorphin, have been
used to direct the differentiation of hESCs/hiPSCs toward
the neural lineage [12]. In addition, Lefty-A or the small
molecule SB431542 can be used to inhibit Nodal, a member
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of the transforming growth factor (TGF) 𝛽 family which
contributes to endodermal or mesodermal fate selection,
promoting neural induction of hESCs. The combination of
a BMP antagonist and a TGF𝛽/Activin/Nodal inhibitor has
been used to accelerate the neural induction of hESCs/hiPSCs
[11, 13–15]. To establish a reproducible EB-based method,
Eiraku et al. subjected fully dissociated hESCs/hiPSCs to
SFEBq (serum-free culture of EB-like aggregates) in the pres-
ence of a Rho-associated protein kinase (ROCK) inhibitor,
resulting in the formation of uniformly sized EBs [16]. It
has also been shown that neural precursor cells can be
derived from hESCs at physiological oxygen levels (3 to 5%)
[17].
Neural induction using these methods has been suc-
cessful for only a limited number of hESC/hiPSC clones.
Koyanagi-Aoi et al. recently reported on the SFEBq-mediated
induction of dopaminergic neurons from hESCs and hiPSCs
derived from various somatic tissues [18]. The aim of the
current study was to determine whether hNPCs can be
derived from any hiPSC clone regardless of its somatic tissue
origin. We evaluated 21 hiPSC clones derived from human
dermal fibroblasts (HDFs, 13 clones), cord blood (CB) cells
(3 clones), and peripheral blood mononuclear (PBMN) cells
(5 clones) using an EB formation-based method (EBFM)
and an EB formation method that includes dual SMAD
inhibitors (dSMADi). Although there is consensus that
SMAD inhibition is necessary for neural induction as men-
tioned above, there are many variations among methods.
Therefore, we performed the dSMADi method, in which
the conditions are easily controlled, using two types of
media and two different oxygen levels. Thus, the previously
reported neural induction method was expanded into four
conditions. Our data indicate that dual SMAD inhibition
can be used to generate mid/hindbrain-type hNPCs from
hiPSCs regardless of their somatic tissue origin. These
expandable hNPCs may be a useful cell source for regen-
erative medicine research and the treatment of neuronal
diseases.
2. Materials and Methods
2.1. Culture of hiPSCs. This study was conducted in accor-
dance with the principles of the Helsinki Declaration, and the
use of hiPSC clones was approved by the ethics committee of
Osaka National Hospital (number 110) and CiRA, Kyoto Uni-
versity. All hiPSC clones (Table S1 in SupplementaryMaterial
available online at http://dx.doi.org/10.1155/2016/7235757)
were cultured at the CiRA on mitomycin C-treated SNL
feeder cells in primate ES cell medium (ReproCELL) until
∼50% confluent and then transported to our laboratory at
Osaka National Hospital. The hiPSC clones were cultured for
two days before neural induction.
2.2. Neural Induction of hiPSCs. Two neural inductionmeth-
ods were used in this study: EBFM [19, 20] and an EB forma-
tion method using dual SMAD inhibitors (dSMADi) [14, 16].
Each of the hiPSC clones was simultaneously subjected to
neural induction using the two methods.
For EBFM, the hiPSCs were treated with 10𝜇M Y-27632
(ROCK inhibitor) for 1 h at 37∘C and then detached using
1mg/mL collagenase IV (Life Technologies) and floated onto
gelatin-coated dishes to remove the SNL feeder cells. After
30min, floating EBs were transferred to Petri dishes contain-
ing DMEM/F12 (D6421, Sigma) with 20% knockout serum
replacement (KSR, Life Technologies), 0.1mM nonessential
amino acids (NEAA, Life Technologies), 2mM L-glutamine
(Life Technologies), 0.1mM 2-Mercaptoethanol (2-ME, Life
Technologies), antibiotic-antimycotic (Life Technologies),
and 10 𝜇MY-27632 (day 0).The next day (day 1), the medium
was replaced with 5% KSR-containing medium and cultured
further for 30 days with a medium change every two days.
For dSMADi, hiPSCs were treated with 10 𝜇M Y-27632
for 1 h at 37∘C and then dissociated with Trypsin/EDTA
to generate single-cell suspensions and suspended in two
types of medium: KSR-based medium [DMEM/F12 (D6421)
with 20% KSR, 0.1mM 2-ME, 10 𝜇M SB-431542 (SB, Sigma),
and 2 𝜇M Dorsomorphin (DSM, Wako)] and B27N2-based
medium [DMEM/F12 (D8062) with 15mM HEPES, 5% B27,
5% N2 supplement (N2, Life Technologies), 10 𝜇M SB, 2 𝜇M
DSM, and 10 ng/mL bFGF]. Both media were supplemented
with 30 𝜇M Y-27632 for the first 3 days. Completely disso-
ciated cells were then seeded into ultralow attachment 96-
well plates (PrimeSurface 96-well, Sumitomo Bakelite) at
9,000 cells/well, centrifuged at 700 rpm for 3min (quick-
aggregation), and cultured in a 5% CO
2
incubator with
5 or 20% O
2
. Thus, the dSMADi neural induction was







, and B27N2/5% O
2
. The cells were
cultured for 14 days with daily replacement of half the spent
medium with fresh medium. On day 14, the aggregates were
dissociated mechanically and cultured on Petri dishes in a
5% CO
2
incubator with 20% O
2
to generate the first passage
of hNPCs. Neurospheres were generated from the second
passage of NPCs by completely dissociating the cells with
Accutase (Innovative Cell Technologies) and then cultured
on nontreated flasks. If the hNPCs attached to the culture
vessels at early passages, we used ultralow attachment dishes
(PrimeSurface, SumitomoBakelite) to establish the hNPCs as
neurospheres.
2.3. Maintenance of hNPCs. The hNPCs were seeded at 1
× 105 cells/mL and cultured as floating neurospheres in
hNPC medium [DMEM/F12 (D8062) with 15mM HEPES,
2% B27, 20 ng/mL EGF (PeproTech), 20 ng/mL FGF2 (Pepro-
Tech), 10 ng/mL leukemia inhibitory factor (Millipore), and
5 𝜇g/mL heparin (Sigma-Aldrich)].
2.4. Quantitative Reverse Transcription-Polymerase Chain
Reaction (Quantitative RT-PCR). Total RNA was extracted
using the RNeasy MinElute Cleaning Kit (Qiagen), and the
cDNAs were synthesized using the PrimeScript RT Master
Mix (Takara Bio) according to the manufacturer’s specifica-
tions. Quantitative PCR analysis was performed using gene-
specific primers (Table S4), the Power SYBR Green PCR
Master Mix, and the 7300 Real-Time PCR System (Applied
Biosystems). Gene expression levels were expressed as delta
Ct values normalized to GAPDH [23].
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2.5. Measurement of Neural Aggregate Size. Phase-contrast
images of eight wells per condition for each clone were
captured (one representative image per condition is shown
in Figure S3). The projected areas of the neural aggregates
were measured using ImageJ [24]. The aggregate size was
calculated as a sphere volume using the circular diameter
determined from the projected area [25].
2.6. In Vitro Neuronal Differentiation. To avoid disturbing
the naturally formed niche, the neurospheres were not dis-
sociated. The intact neurospheres were transferred to vessels
coated with Growth Factor Reduced Matrigel (diluted to
1 : 30, BD Biosciences) and cultured in Neurobasal Medium
(Life Technologies) containing 2% B27 and 1% L-glutamine
for 2 weeks [22].
2.7. Immunocytochemical Staining. Cells were fixed in 4%
paraformaldehyde and washed with PBS. The fixed samples
were then blocked with 10% normal goat serum and incu-
bated with anti-𝛽III tubulin antibody (clone TuJ1, Babco)
overnight at 4∘C. The samples were then incubated with
AlexaFluor-488-conjugated goat anti-mouse IgG (Molecular
Probes, Life Technologies) for 1 h at room temperature.
The stained samples were examined with a confocal laser-
scanning microscope. All staining procedures were per-
formed with matched-isotype controls [22].
2.8. Neurite Analysis. 𝛽III tubulin-positive neurites in four
regions were detected by appropriate thresholding and then
skeletonized using ImageJ [24]. Total neurite length was
determined by counting the positive pixels [26].
2.9. Statistical Analysis. Significant differences in gene ex-
pression levels obtained by quantitative RT-PCR were ana-
lyzed using the Steel-Dwass nonparametricmultiple compar-
ison test or Welch’s 𝑡-test. Significant differences in neural
aggregate size were also analyzed by the Steel-Dwass compar-
ison test. Significant differences in total neurite length were
analyzed by Dunnett’s test. See figure legends for details.
3. Results and Discussion
There are many variations among neural induction methods,
although there is consensus about the necessity of SMAD
inhibition. To determine whether hiPSC clones derived
from different somatic tissues could differentiate into hNPCs
without specific neural induction methods (Figure 1(a)), we
examined 21 hiPSC clones established in CiRA (Table S1).
These hiPSC clones were derived from three different tissues:
HDFs, CB cells, and PBMN cells (Table S1).
All of the hiPSCs exhibited a typical undifferentiated
hESC-like morphology (Figure S1A). Quantitative RT-PCR
showed that the clones expressed uniformly high levels of
the pluripotency marker genes Oct4, NANOG, and LIN28A
but very low levels of the differentiation marker genes SOX17
(endoderm), T (mesoderm), and SOX1 and PAX6 (both
neural) just prior to neural induction (Figure 1(b) and Figure
S1B).
Two predominant methods for inducing the neural
differentiation of hESCs/hiPSCs are the EB formation-
based method (EBFM) and EB formation with dual SMAD
inhibitors (dSMADi). We controlled the aggregate size in the
dSMADi method using a quick-aggregation procedure [16]
and examined four additional conditions using this method
by assessing combinations of two culture media and two
different oxygen levels. In the EBFM approach, we used a low
concentration (5%) of knockout serum replacement (KSR)
[19, 20] to limit the amount of BMP-like activity [27], which
opposes neural induction and is present in the KSR.
We subjected the 21 hiPSC clones to the five different
neural induction procedures (Figure 1(a)). To assess the
neural induction efficiency using dSMADi, we compared
gene expression levels among the hiPSCs, day 30 EBFM-
derived EBs, and day 14 dSMADi-derived aggregates, by
quantitative RT-PCR (Figure 1(b), Figure S1B, Figure S1C, and
Figure S2). Bivariate box plots showed that the pluripotency
marker genes, Oct4 and NANOG, were strongly and uni-
formly downregulated in day 14 dSMADi-derived aggregates
but not in day 30 EBFM-derived EBs, which exhibited more
variable expression among the clones (Figure 1(b) and Figure
S1C). Interestingly, dSMADi treatment also resulted in the
slight downregulation of another pluripotency marker gene,
LIN28A (Figure 1(b)).
Day 30 EBs did not uniformly express the endoderm
marker gene SOX17, mesoderm marker gene T, or neural
marker genes SOX1 and PAX6 and were classified as nonneu-
ral, neural, or three germ layer-containing EBs (Figure S1D).
In contrast, almost all of the day 14 dSMADi-derived aggre-
gates exhibited the upregulation of both neural marker genes
but not nonneural marker genes (Figure 1(b)).These findings
indicated that while EBFM-derived EBs exhibited cell lineage
variability (only 6 clones differentiated toward specifically
neural lineage), dSMADi-derived aggregates exhibited less
clonal variation, and almost all of them underwent neural
lineage induction regardless of somatic tissue origin and the
differentiation protocols (over 90% of clones differentiated
toward neural lineage). Hereafter, we will refer to day 14
dSMADi aggregates as neural aggregates.
We further evaluated the effects of the four dSMADi
conditions by comparing the gene expression levels of the
neural aggregates derived in two types of media (KSR or
B27N2) and two different oxygen levels (20% or 5%) (Fig-
ure 2(a)). Although the expression levels of the pluripotency
marker gene Oct4 and neural marker gene SOX1 were
similar in aggregates cultured in the four conditions, those
of NANOG in aggregates cultured in KSR/5% O
2
and of




were significantly higher than in the B27N2-based conditions
(Figure 2(a)). The oxygen level alone did not significantly
impact the expression levels of these genes. Althoughwe used
a quick-aggregation procedure in the dSMADi experiments
to eliminate the size and shape variability observed in EBFM-
derived EBs (Figure S1A), we noticed obvious differences in
neural aggregate size among the four conditions (Figure S3).
To examine the effects of the culture conditions in detail,
we measured the size of the neural aggregates on day 7 and
day 14 (Figure 2(b)). The day 14 neural aggregates cultured in
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Figure 1: dSMADi improves the neural induction efficiency of hiPSCs regardless of their somatic tissue origin. (a) Schematic drawing of the
neural induction methods used in this study. (b) Bivariate box plots displaying gene expression levels in hiPSCs, day 30 EBFM-derived EBs,
and day 14 dSMADi-derived aggregates. Quantitative RT-PCR-generated delta Ct values for the pluripotency marker genes (Oct4, NANOG,
and LIN28A), endoderm marker gene (SOX17), mesoderm marker gene (T), and neural marker genes (SOX1 and PAX6) are shown. Green:
hiPSCs; red: EBFM; blue: dSMADi.The numbers of clones analyzed are indicated in parentheses and “+” symbols represent each of the delta
Ct values. Filled-in regions contain the 50% of the data points, and data points outside of the surrounding lines represent outliers. See also
Figures S1 and S2.
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Figure 2: Effects of media and oxygen level on neural aggregate gene expression and size. (a) Dot plots and box plots showing for the
gene expression levels of pluripotency markers (Oct4 and NANOG) and neural markers (SOX1 and PAX6) in day 14 aggregates cultured in
the various conditions. Twenty-one clones were analyzed in each condition. Statistical significance was determined by the Steel-Dwass test.
Statistically significant differences (𝑝 < 0.01) were found between samples “A” and “B”. See also Figure S2. (b) Dot plot and box plot showing
the size of day 7 and day 14 neural aggregates. Statistical analysis was performed with the Steel-Dwass test (∗∗𝑝 < 0.01). All 𝑝 values are shown
in Table S2.
B27N2-based conditions were significantly larger than those
cultured in KSR-based conditions at each oxygen level, and
they were also significantly larger when cultured in 20% O
2
than in 5% O
2
, in both types of media (Figure 2(b) and
Table S2). Notably, neural aggregates did not grow in the
KSR-based conditions over the induction period regardless
of the oxygen level. In contrast, B27N2, which contains
basic fibroblast growth factor, supported the growth of the
neural aggregates (Figure 2(b)).These findings indicated that
although the four dSMADi conditions efficiently promoted
neural lineage induction, the culture medium influenced
both gene expression and aggregate size, whereas the oxygen
level primarily affected aggregate size.
Next, we investigated whether the neural aggregates
exhibited a forebrain-type property, as previously observed
for lt-NES cells and R-NSCs [8–10]. Because the expression
of PAX6 was higher in KSR-derived aggregates than in
B27N2-derived aggregates, we first compared the expression
levels of the forebrain marker genes, FOXG1 and OTX1, in
day 14 neural aggregates cultured in all four conditions.
Although there were no significant differences in FOXG1
and OTX1 expression levels among aggregates cultured in
the different conditions (Figure 3(a)), the FOXG1 expression
was more variable among the clones compared to the OTX1
expression. Therefore, we compared the FOXG1 expression
among aggregates derived from somatic tissues of different
origins (Figure 3(b)). Notably, the FOXG1 expression was
significantly lower in the clones derived from PBMN cells
than in those derived from HDFs and CB cells (Figure 3(b)),
although the HDF- and CB cell-derived clones exhibited
variable FOXG1 expression. Given that ES cells generate
anterior forebrain-like neural precursor cells in the absence
of external signals [28], the variability of FOXG1 expression in
the HDF- and CB-derived clones might reflect variable Wnt
activation in the hiPSCs [29].
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Figure 3: PBMN-derived neural aggregates exhibit low FOXG1 expression levels. (a) Dot plots and box plots showing FOXG1 and OTX1
expression in day 14 neural aggregates cultured in the various conditions. (b) Dot plots and box plots showing the FOXG1 expression levels
according to tissue origin. The number of clones analyzed is indicated in parentheses. Statistical analysis was performed by the Steel-Dwass
test. ∗∗𝑝 < 0.01. (c) Clustering of clones, based on the expression of FOXG1 and SOX1, using the𝐾-medoids method. The delta Ct values are
indicated by “+” symbols. Four clusters were identified: FOXG1-high/SOX1-high (red), FOXG1-middle/SOX1-high (green), FOXG1-low/SOX1-
high (black), and FOXG1-low/SOX1-low (pink). See also Table S3.
However, the mechanisms regulating differential FOXG1
expression between CB- and PBMN-derived clones are
unclear because both hiPSC clones were derived from meso-
dermal tissues, cultured for over 20 passages, and were
considered to have lost their somatic tissue-specific epige-
netic memory [30–32]. Given that all of the PBMN cells
were 𝛼𝛽T cells in this study, their genomes were modified
due to T-cell receptor (TCR) rearrangement, in contrast to
the HDF and CB cells. The genes encoding T-cell receptor
alpha (TRA) and T-cell receptor beta (TRB) are located at
chromosomal regions 14q11.2 and 7q34, respectively. FOXG1
is located at chromosomal region 14q13. Although TRA
and FOXG1 are separated by about 6 million bases, some
epigenetic modifications might still occur in the regulatory
region of FOXG1. FOXG1 is critical for normal corticogen-
esis [33]; therefore, PBMN-derived hiPSCs might not be a
good source for analyzing normal cortical development or
disease modeling. Further studies are required to elucidate
whether inhibition of Wnt signaling improves the induction
of anterior neural progenitors from PBMN-derived clones.
On the other hand, we hypothesized that neural aggregates
with the potential for producing uniform hNPCs could be
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Figure 4: Established hNPCs express regional markers indicative of a mid/hindbrain-type property. (a) Morphologies of the expanded
neurospheres at approximately passage 6 (upper panel). 𝛽III tubulin-positive neurons after 14 days of neuronal differentiation. Green: 𝛽III
tubulin; blue: nucleus (lower panel). Scale bars: 500 𝜇m(black) and 50 𝜇m(white). (b)Neurite analysis after 14 days of neuronal differentiation.
Relative total neurite length is shown as the mean ± SD. Statistical analysis was performed using Dunnett’s test. ∗𝑝 < 0.05 and ∗∗𝑝 < 0.01.
(c) Dot plots and box plots showing the expression of forebrain markers (FOXG1 and OTX1), mid/hindbrain markers (EN1 and GBX2), and
a spinal cord marker (HOXC6) in day 14 (D14) neural aggregates and neurospheres at approximately passage 6 (P6). The numbers of clones
analyzed are shown in parentheses. Statistical analysis was performed usingWelch’s two-sample 𝑡-test. ∗∗𝑝 < 0.01. (d) Hierarchical clustering
of clones based on neural progenitor marker expression. Red: high gene expression; green: low gene expression.
identified by screening for FOXG1 expression. To evaluate this
possibility, we grouped all of the neural aggregates into four
categories (FOXG1-high/SOX1-high, FOXG1-middle/SOX1-
high, FOXG1-low/SOX1-high, and FOXG1-low/SOX1-low) by
clustering based on FOXG1 and SOX1 expression levels
(Figure 3(c) andTable S3).We then selected neural aggregates
from each category, except for the SOX1-low, nonneural
lineage category, for further expansion. Notably, these neural
aggregates included clones derived from each of the three
different tissue types (Table S3).
To facilitate the expansion of homogeneous populations
of hNPCs, we cultured them as floating neurospheres [22]
rather than as adherent cells like lt-NES cells. Expandable
neurospheres were established at approximately passage 6
regardless of the FOXG1 expression level in day 14 neu-
ral aggregates or the somatic tissue origin (Figure 4(a)).
To confirm that the neurospheres were hNPCs, neuronal
differentiation was induced using the serum-free neuronal
differentiation protocol. All of the HDF- and CB cell-derived
neurospheres differentiated into 𝛽III tubulin-positive neu-
rons with long neurites, whereas only two of the five PBMN
cell-derived neurospheres underwent neuronal differentia-
tion (Figures 4(a) and 4(b)). Notably, all of the clones that
failed to differentiate were derived from the hiPSC clone
604A3 (Figures 4(a) and 4(b)). These results also indicated
that hNPC establishment was independent of the FOXG1
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expression level in day 14 neural aggregates and of the hiPSC
somatic tissue origin. FOXG1 expression decreases with
increasing passage of lt-NES cells [9, 10] and neurospheres
[22]. Thus, we hypothesized that FOXG1 expression in day
14 neural aggregates may decrease over time, resulting in
the formation of mid/hindbrain-type progenitors. To assess
this supposition, we compared the expression of regional
identitymarker genes in day 14 neural aggregates and passage
6 neurospheres (Figure 4(c)). We found that the neural
aggregates expressed variable levels of not only the forebrain
markers, FOXG1 andOTX1, but also eachmarker gene for the
mid/hindbrain (EN1/GBX2) and spinal cord (HOXC6) (Fig-
ure 4(c)).These broad expression patterns of regional marker
genes were consistent with a previous report on the activity
of endogenous Wnt signaling [34]. In contrast, passage 6
neurospheres expressed higher and less variable levels of the
mid/hindbrain markers and reduced levels of the forebrain
and spinal cord markers (Figure 4(c)). Thus, while the day
14 neural aggregates exhibited upregulated forebrain marker
expression, established hNPCs displayed a mid/hindbrain-
like regional property, consistent with previous findings [22].
Finally, we compared the expression of neural progenitor
genes among the established hNPCs (Figure 4(d)). We found
that hNPCs and 604A3-derived non-hNPCs were separately
clustered and that the hNPCs exhibited similar neural pro-
genitor gene expression patterns regardless of the dSMADi
conditions and their somatic tissue origin. All of the PBMN
clones met our criteria of high SOX1 and PAX6 expressions
on day 14 (Figure 3(c)). All three of the 604A3 clones had
almost the same properties on day 14 but differed from
the other clones at passage 6 (Figure 4(d)). We could not
eliminate the possibility that the day 14 neural aggregates
contained nonneural cells, because gene expression analysis
was performed on the bulk population, not at the single-cell
level. Therefore, we applied the neurosphere culture method
to select a homogeneous population and we were successful
in almost every case. However, given that at least neural crest
cells can grow in our neurosphere conditions [35], some cell
population thatwas preferentially induced in the 604A3 clone
might have been selected and expanded in the neurosphere
culture process.
4. Conclusions
We conclude that neural lineage cells can be derived from
most hiPSC clones, regardless of their somatic tissue origin,
using dual SMAD inhibition. We found that PBMN cell-
derived hiPSC clones did not exhibit increased expression
of the forebrain marker gene, FOXG1, but generated hNPCs
with neuronal differentiation ability as efficiently as HDF-
and CB-derived hiPSC clones. Moreover, neural aggregates
at the early neural induction stage exhibited variable neural
regional marker gene expression patterns and gave rise
to hNPCs that uniformly exhibited a mid/hindbrain-type
property and expressed similar levels of neural progenitor
genes. These findings suggest that the hNPCs described here
may be a useful cell source for basic and pharmaceutical
research aimed at developing regenerative therapies for treat-
ing various neuronal diseases.
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